M Pharmaceutical Inc. (DB:T3F1) intends to pursue acquisitions. The Company is undertaking a non-brokered private placement of up to $0.75 million. First Sahara intends to use the proceeds for general working capital, including the review of possible acquisitions.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | +9,900.00% |
2018 | James Thompson to Assume the Position of President and Chief Executive Officer of Callitas Health Inc | CI |
2018 | Callitas Health Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 4.53K | |
+32.89% | 50.85B | |
+0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.38% | 26.11B | |
-22.19% | 19.13B | |
+8.41% | 13.05B | |
+27.13% | 12.16B | |
+24.72% | 12.08B |
- Stock Market
- Equities
- MPHMF Stock
- News Callitas Health Inc.
- First Sahara Mulls Acquisitions